Mechanistic comparison of Esculin and alyssin [Supplementary Concept] based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
17%
Jaccard Similarity
15%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Esculin and alyssin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.167 means 17% of the combined target set is bound by both compounds. The IDF-weighted score of 0.152 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Esculin and alyssin have in common?
Esculin and alyssin share 2 molecular targets with a Jaccard similarity of 17%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Esculin and alyssin be combined?
Esculin and alyssin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Esculin or alyssin?
In the BiohacksAI corpus: Esculin has 300 PubMed-indexed studies, alyssin has 300 studies.